News updates: nano-based vaccines and therapeutics for treatment of COVID-19

Written by Ilana Landau and Lucy Chard

COVID-19 vaccine trials and updates

A timeline of responses from researchers, biotechnology companies and funding bodies in a global effort to develop, test and distribute vaccines and therapeutics for COVID-19 as quickly and safely as possible.   MHRA grants emergency use authorization for Pfizer/BioNTech’s mRNA COVID-19 vaccine candidate Pfizer (NY, USA) and BioNTech (Mainz, Germany) have announced that the UK’s regulator, MHRA, has granted a temporary authorization for emergency use of the companies’ COVID-19 mRNA vaccine candidate, BNT162b2. Albert Bourla, Chairman and CEO at Pfizer, commented: “Today’s Emergency Use Authorization in the U.K. marks a historic moment in the fight against COVID-19. This authorization is...

To view this content, please register now for access

It's completely free